These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 10377279)

  • 1. Cardiac hypertrophy: sorting out the circuitry.
    McKinsey TA; Olson EN
    Curr Opin Genet Dev; 1999 Jun; 9(3):267-74. PubMed ID: 10377279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calcineurin and beyond: cardiac hypertrophic signaling.
    Molkentin JD
    Circ Res; 2000 Oct; 87(9):731-8. PubMed ID: 11055975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcineurin-NFAT signaling regulates the cardiac hypertrophic response in coordination with the MAPKs.
    Molkentin JD
    Cardiovasc Res; 2004 Aug; 63(3):467-75. PubMed ID: 15276472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CaM kinase signaling induces cardiac hypertrophy and activates the MEF2 transcription factor in vivo.
    Passier R; Zeng H; Frey N; Naya FJ; Nicol RL; McKinsey TA; Overbeek P; Richardson JA; Grant SR; Olson EN
    J Clin Invest; 2000 May; 105(10):1395-406. PubMed ID: 10811847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcineurin/NFAT coupling participates in pathological, but not physiological, cardiac hypertrophy.
    Wilkins BJ; Dai YS; Bueno OF; Parsons SA; Xu J; Plank DM; Jones F; Kimball TR; Molkentin JD
    Circ Res; 2004 Jan; 94(1):110-8. PubMed ID: 14656927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct and indirect interactions between calcineurin-NFAT and MEK1-extracellular signal-regulated kinase 1/2 signaling pathways regulate cardiac gene expression and cellular growth.
    Sanna B; Bueno OF; Dai YS; Wilkins BJ; Molkentin JD
    Mol Cell Biol; 2005 Feb; 25(3):865-78. PubMed ID: 15657416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interference of antihypertrophic molecules and signaling pathways with the Ca2+-calcineurin-NFAT cascade in cardiac myocytes.
    Fiedler B; Wollert KC
    Cardiovasc Res; 2004 Aug; 63(3):450-7. PubMed ID: 15276470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Signaling path may lead to better heart-failure therapies.
    Barinaga M
    Science; 1998 Apr; 280(5362):383. PubMed ID: 9575084
    [No Abstract]   [Full Text] [Related]  

  • 9. Calcium-calcineurin signaling in the regulation of cardiac hypertrophy.
    Wilkins BJ; Molkentin JD
    Biochem Biophys Res Commun; 2004 Oct; 322(4):1178-91. PubMed ID: 15336966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversal of cardiac hypertrophy in transgenic disease models by calcineurin inhibition.
    Lim HW; De Windt LJ; Mante J; Kimball TR; Witt SA; Sussman MA; Molkentin JD
    J Mol Cell Cardiol; 2000 Apr; 32(4):697-709. PubMed ID: 10756124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased KCNE2 Expression Participates in the Development of Cardiac Hypertrophy by Regulation of Calcineurin-NFAT (Nuclear Factor of Activated T Cells) and Mitogen-Activated Protein Kinase Pathways.
    Liu W; Deng J; Ding W; Wang G; Shen Y; Zheng J; Zhang X; Luo Y; Lv C; Wang Y; Chen L; Yan D; Boudreau RL; Song LS; Liu J
    Circ Heart Fail; 2017 Jun; 10(6):. PubMed ID: 28611128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IGF-1 induces skeletal myocyte hypertrophy through calcineurin in association with GATA-2 and NF-ATc1.
    Musarò A; McCullagh KJ; Naya FJ; Olson EN; Rosenthal N
    Nature; 1999 Aug; 400(6744):581-5. PubMed ID: 10448862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LIM and cysteine-rich domains 1 regulates cardiac hypertrophy by targeting calcineurin/nuclear factor of activated T cells signaling.
    Bian ZY; Huang H; Jiang H; Shen DF; Yan L; Zhu LH; Wang L; Cao F; Liu C; Tang QZ; Li H
    Hypertension; 2010 Feb; 55(2):257-63. PubMed ID: 20026769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted inhibition of p38 MAPK promotes hypertrophic cardiomyopathy through upregulation of calcineurin-NFAT signaling.
    Braz JC; Bueno OF; Liang Q; Wilkins BJ; Dai YS; Parsons S; Braunwart J; Glascock BJ; Klevitsky R; Kimball TF; Hewett TE; Molkentin JD
    J Clin Invest; 2003 May; 111(10):1475-86. PubMed ID: 12750397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcineurin anchoring and cell signaling.
    Dodge KL; Scott JD
    Biochem Biophys Res Commun; 2003 Nov; 311(4):1111-5. PubMed ID: 14623297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcineurin in human heart hypertrophy.
    Ritter O; Hack S; Schuh K; Röthlein N; Perrot A; Osterziel KJ; Schulte HD; Neyses L
    Circulation; 2002 May; 105(19):2265-9. PubMed ID: 12010908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calmodulin kinases II and IV and calcineurin are involved in leukemia inhibitory factor-induced cardiac hypertrophy in rats.
    Kato T; Sano M; Miyoshi S; Sato T; Hakuno D; Ishida H; Kinoshita-Nakazawa H; Fukuda K; Ogawa S
    Circ Res; 2000 Nov; 87(10):937-45. PubMed ID: 11073891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcineurin independent development of myocardial hypertrophy in transgenic rats overexpressing the mouse renin gene, TGR(mREN2)27.
    Diedrichs H; Mei C; Frank KF; Boelck B; Schwinger RH
    J Mol Med (Berl); 2004 Oct; 82(10):688-95. PubMed ID: 15322704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activated glycogen synthase-3 beta suppresses cardiac hypertrophy in vivo.
    Antos CL; McKinsey TA; Frey N; Kutschke W; McAnally J; Shelton JM; Richardson JA; Hill JA; Olson EN
    Proc Natl Acad Sci U S A; 2002 Jan; 99(2):907-12. PubMed ID: 11782539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heme oxygenase-1 inhibition of MAP kinases, calcineurin/NFAT signaling, and hypertrophy in cardiac myocytes.
    Tongers J; Fiedler B; König D; Kempf T; Klein G; Heineke J; Kraft T; Gambaryan S; Lohmann SM; Drexler H; Wollert KC
    Cardiovasc Res; 2004 Aug; 63(3):545-52. PubMed ID: 15276480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.